Cargando…
HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial
Autores principales: | Mosam, Anisa, Shaik, F, Uldrick, T, Esterhuizen, T, Friedland, G, Scadden, D, Aboobaker, J, Coovadia, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002689/ http://dx.doi.org/10.1186/1750-9378-5-S1-A30 |
Ejemplares similares
-
The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
por: Mosam, A, et al.
Publicado: (2010) -
Health-Related Quality of Life in Patients Treated With
Antiretroviral Therapy Only Versus Chemotherapy and Antiretroviral Therapy for
HIV-Associated Kaposi Sarcoma: A Randomized Control Trial
por: Shaik, Fahmida, et al.
Publicado: (2018) -
Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770
por: Uldrick, TS, et al.
Publicado: (2009) -
Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006)
por: Uldrick, TS, et al.
Publicado: (2009) -
The interaction between smoking status and highly active antiretroviral therapy (HAART) use on the risk of Kaposi's sarcoma (KS) in a cohort of HIV-infected men
por: Luu, H N, et al.
Publicado: (2013)